| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
72,387 |
65,511 |
$34.58M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
89,970 |
80,196 |
$26.17M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
81,460 |
71,283 |
$24.51M |
| J9271 |
Injection, pembrolizumab, 1 mg |
3,207 |
2,284 |
$17.83M |
| OP250 |
|
316,512 |
193,044 |
$16.51M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
13,858 |
13,123 |
$16.35M |
| G0378 |
Hospital observation service, per hour |
40,356 |
21,649 |
$15.57M |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
45,720 |
35,960 |
$8.85M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
43,075 |
27,001 |
$7.82M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
26,503 |
16,343 |
$6.93M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
2,927 |
2,872 |
$6.65M |
| 64483 |
|
5,662 |
5,329 |
$5.84M |
| J2505 |
Injection, pegfilgrastim, 6 mg |
1,993 |
1,539 |
$5.33M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
7,303 |
6,837 |
$5.14M |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
3,855 |
3,507 |
$4.54M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
7,533 |
7,325 |
$3.44M |
| 59025 |
Fetal non-stress test |
10,531 |
6,043 |
$3.40M |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
3,679 |
3,487 |
$3.06M |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
13,419 |
12,031 |
$2.91M |
| 77386 |
|
13,954 |
1,259 |
$2.89M |
| OP710 |
|
32,213 |
29,638 |
$2.54M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
67,027 |
59,530 |
$2.51M |
| 64493 |
|
2,110 |
2,014 |
$2.33M |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
23,151 |
22,696 |
$2.28M |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
1,236 |
1,075 |
$2.25M |
| J9299 |
Injection, nivolumab, 1 mg |
459 |
296 |
$2.24M |
| J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
1,153 |
782 |
$2.14M |
| Q5115 |
Injection, rituximab-abbs, biosimilar, (truxima), 10 mg |
1,204 |
545 |
$2.13M |
| 93458 |
|
905 |
866 |
$2.10M |
| 62321 |
|
2,034 |
1,908 |
$2.09M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
19,406 |
16,259 |
$1.98M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
18,601 |
17,170 |
$1.97M |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
4,651 |
4,257 |
$1.96M |
| J9305 |
Injection, pemetrexed, not otherwise specified, 10 mg |
1,005 |
482 |
$1.92M |
| 96417 |
|
6,791 |
4,385 |
$1.90M |
| 96415 |
|
8,117 |
5,588 |
$1.85M |
| OP272 |
|
36,249 |
33,132 |
$1.74M |
| Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg |
1,533 |
674 |
$1.73M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
24,743 |
23,015 |
$1.72M |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
2,612 |
2,481 |
$1.72M |
| 96411 |
|
3,806 |
2,476 |
$1.70M |
| Q5111 |
Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg |
1,041 |
794 |
$1.67M |
| J0897 |
Injection, denosumab, 1 mg |
1,659 |
1,491 |
$1.46M |
| 62323 |
|
1,604 |
1,518 |
$1.42M |
| 95816 |
|
3,730 |
3,625 |
$1.39M |
| 64635 |
|
1,220 |
1,163 |
$1.35M |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
3,616 |
3,488 |
$1.34M |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
7,974 |
7,745 |
$1.31M |
| OP278 |
|
1,261 |
1,198 |
$1.30M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
29,841 |
24,739 |
$1.30M |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
4,321 |
4,215 |
$1.27M |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
4,359 |
4,216 |
$1.24M |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
55,683 |
50,722 |
$1.18M |
| J9312 |
Injection, rituximab, 10 mg |
278 |
194 |
$1.16M |
| 43235 |
|
1,033 |
975 |
$1.12M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
23,054 |
14,731 |
$1.11M |
| J9355 |
Injection, trastuzumab, excludes biosimilar, 10 mg |
411 |
242 |
$1.08M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
17,546 |
9,977 |
$1.08M |
| 36415 |
Collection of venous blood by venipuncture |
159,478 |
123,937 |
$1.04M |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
10,443 |
9,799 |
$1.02M |
| 64490 |
|
971 |
919 |
$1.02M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,309 |
10,198 |
$916K |
| 94070 |
|
1,538 |
1,501 |
$908K |
| 71046 |
Radiologic examination, chest; 2 views |
48,478 |
44,708 |
$876K |
| C1776 |
Joint device (implantable) |
912 |
775 |
$852K |
| 74183 |
|
2,375 |
2,311 |
$849K |
| 96416 |
|
3,639 |
2,184 |
$848K |
| 36561 |
|
733 |
674 |
$837K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
723 |
686 |
$817K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
939 |
816 |
$812K |
| 95806 |
|
2,777 |
2,765 |
$806K |
| 92557 |
|
3,914 |
3,867 |
$795K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
33,089 |
30,374 |
$766K |
| A0431 |
Ambulance service, conventional air services, transport, one way (rotary wing) |
434 |
390 |
$754K |
| 77412 |
|
10,476 |
1,251 |
$752K |
| 70450 |
Computed tomography, head or brain; without contrast material |
18,681 |
17,117 |
$739K |
| 64721 |
|
742 |
707 |
$728K |
| 72141 |
|
2,662 |
2,586 |
$724K |
| 94060 |
|
2,590 |
2,539 |
$692K |
| 19083 |
|
689 |
663 |
$690K |
| 93971 |
|
4,044 |
3,821 |
$680K |
| 77334 |
|
2,756 |
2,053 |
$676K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
7,626 |
4,833 |
$672K |
| 94010 |
|
2,946 |
2,844 |
$669K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
30,775 |
24,859 |
$655K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
46,702 |
29,347 |
$652K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
412 |
397 |
$639K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
11,502 |
4,921 |
$637K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
11,544 |
10,969 |
$629K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
60,410 |
50,506 |
$617K |
| 71250 |
|
5,343 |
5,172 |
$584K |
| 93970 |
|
2,765 |
2,609 |
$576K |
| 82948 |
|
57,506 |
39,506 |
$575K |
| 94750 |
|
2,022 |
2,019 |
$568K |
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
118 |
112 |
$550K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
21,057 |
20,593 |
$538K |
| J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj |
162 |
87 |
$516K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
9,158 |
5,767 |
$512K |
| 92567 |
|
6,883 |
6,785 |
$508K |
| 77066 |
Tomosynthesis, mammo |
4,014 |
3,895 |
$507K |
| A0425 |
Ground mileage, per statute mile |
58,459 |
44,818 |
$497K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,813 |
1,697 |
$493K |
| 94729 |
|
6,207 |
6,027 |
$478K |
| 73221 |
|
1,754 |
1,693 |
$471K |
| 95950 |
|
271 |
120 |
$461K |
| 31575 |
|
710 |
621 |
$456K |
| J0185 |
Injection, aprepitant, 1 mg |
2,619 |
1,618 |
$455K |
| 92579 |
|
2,109 |
2,081 |
$444K |
| 76830 |
Ultrasound, transvaginal |
7,044 |
6,856 |
$434K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
4,993 |
4,726 |
$426K |
| 76770 |
|
5,956 |
5,774 |
$420K |
| 77336 |
|
6,280 |
2,840 |
$417K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,531 |
5,633 |
$407K |
| 73030 |
|
10,008 |
9,127 |
$397K |
| J9310 |
Injection, rituximab, 100 mg |
104 |
78 |
$394K |
| 95708 |
|
1,788 |
735 |
$393K |
| 49083 |
|
458 |
238 |
$382K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
4,228 |
4,118 |
$376K |
| 92587 |
|
2,569 |
2,548 |
$375K |
| 76536 |
|
5,042 |
4,898 |
$370K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
9,230 |
8,454 |
$366K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,671 |
3,469 |
$365K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
35,642 |
31,319 |
$360K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
124,411 |
90,700 |
$355K |
| J2704 |
Injection, propofol, 10 mg |
83,770 |
66,513 |
$350K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
107,363 |
85,990 |
$348K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
10,063 |
9,517 |
$346K |
| 94726 |
|
3,951 |
3,786 |
$331K |
| 77300 |
|
1,783 |
1,444 |
$318K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
2,137 |
1,554 |
$312K |
| 58300 |
|
233 |
219 |
$306K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
16,257 |
10,227 |
$306K |
| 96523 |
|
3,976 |
3,116 |
$303K |
| 73630 |
|
11,996 |
10,789 |
$302K |
| 10005 |
|
326 |
301 |
$301K |
| 70486 |
|
4,104 |
3,828 |
$301K |
| J2350 |
Injection, ocrelizumab, 1 mg |
14 |
12 |
$301K |
| J1756 |
Injection, iron sucrose, 1 mg |
7,032 |
3,098 |
$298K |
| 76642 |
|
6,300 |
6,103 |
$298K |
| 77065 |
Tomosynthesis, mammo |
4,068 |
3,751 |
$297K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
5,889 |
5,231 |
$296K |
| 73130 |
|
8,910 |
8,070 |
$293K |
| C1889 |
Implantable/insertable device, not otherwise classified |
2,516 |
2,188 |
$292K |
| C1760 |
Closure device, vascular (implantable/insertable) |
651 |
506 |
$285K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
19,703 |
18,469 |
$279K |
| OP259 |
|
86,333 |
44,034 |
$275K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
802 |
699 |
$271K |
| 74178 |
|
1,181 |
1,091 |
$267K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
14,578 |
12,477 |
$264K |
| 71271 |
|
1,633 |
1,537 |
$263K |
| 70496 |
|
3,033 |
2,702 |
$255K |
| 85027 |
|
70,566 |
54,374 |
$239K |
| 73564 |
|
5,896 |
5,084 |
$238K |
| 72110 |
|
5,233 |
5,112 |
$233K |
| 80053 |
Comprehensive metabolic panel |
36,722 |
32,115 |
$232K |
| 76641 |
|
2,852 |
2,787 |
$227K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
19,692 |
18,476 |
$225K |
| 77301 |
|
427 |
384 |
$224K |
| 86900 |
|
26,188 |
21,571 |
$222K |
| 81025 |
|
24,632 |
22,930 |
$221K |
| 70498 |
|
3,112 |
2,793 |
$213K |
| 84443 |
Thyroid stimulating hormone (TSH) |
24,676 |
22,882 |
$212K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
61,449 |
51,312 |
$208K |
| 88341 |
|
4,505 |
3,798 |
$207K |
| 96401 |
|
2,144 |
1,055 |
$206K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
4,807 |
4,505 |
$205K |
| 70491 |
|
1,783 |
1,659 |
$202K |
| C1769 |
Guide wire |
8,305 |
7,232 |
$198K |
| 96402 |
|
3,152 |
2,780 |
$196K |
| 73610 |
|
7,899 |
7,131 |
$194K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
16,754 |
14,307 |
$193K |
| 27096 |
|
158 |
145 |
$189K |
| J9202 |
Goserelin acetate implant, per 3.6 mg |
475 |
437 |
$185K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
10,410 |
6,678 |
$184K |
| 73110 |
|
5,464 |
4,855 |
$184K |
| 99215 |
Prolong outpt/office vis |
2,164 |
1,970 |
$180K |
| 20553 |
|
190 |
177 |
$175K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,941 |
2,616 |
$173K |
| 20680 |
|
122 |
117 |
$172K |
| 88307 |
|
3,374 |
3,001 |
$170K |
| 77049 |
|
478 |
472 |
$168K |
| 86850 |
|
25,302 |
20,510 |
$167K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
25,455 |
20,712 |
$163K |
| 73560 |
|
8,379 |
7,552 |
$161K |
| 88342 |
|
8,983 |
8,243 |
$157K |
| 74240 |
|
1,384 |
1,355 |
$156K |
| 92588 |
|
847 |
839 |
$154K |
| 87536 |
|
3,172 |
2,965 |
$154K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
3,860 |
1,798 |
$151K |
| 92523 |
|
2,192 |
2,129 |
$148K |
| OP681 |
|
1,061 |
960 |
$145K |
| 52000 |
|
174 |
169 |
$144K |
| 90651 |
|
1,232 |
1,196 |
$142K |
| 72158 |
|
475 |
460 |
$136K |
| C1729 |
Catheter, drainage |
1,586 |
1,112 |
$136K |
| 72100 |
|
4,100 |
3,973 |
$132K |
| 36430 |
|
3,101 |
1,973 |
$132K |
| 80061 |
Lipid panel |
20,805 |
19,802 |
$131K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
340 |
295 |
$129K |
| 77290 |
|
605 |
579 |
$127K |
| 95811 |
|
79 |
78 |
$126K |
| 10022 |
|
137 |
134 |
$126K |
| 20610 |
|
224 |
200 |
$124K |
| 52005 |
|
112 |
111 |
$122K |
| 72050 |
|
2,563 |
2,489 |
$119K |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
2,020 |
1,048 |
$118K |
| 72156 |
|
392 |
379 |
$118K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
25,861 |
20,836 |
$118K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
48,781 |
40,453 |
$117K |
| 71045 |
Radiologic examination, chest; single view |
9,097 |
8,003 |
$115K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
10,108 |
9,469 |
$114K |
| 73080 |
|
3,274 |
2,983 |
$113K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
4,469 |
4,410 |
$113K |
| 78306 |
|
1,085 |
1,028 |
$112K |
| 97161 |
|
8,166 |
7,064 |
$111K |
| 96376 |
|
14,933 |
8,874 |
$111K |
| A4648 |
Tissue marker, implantable, any type, each |
1,201 |
1,106 |
$110K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
8,396 |
7,935 |
$109K |
| 73700 |
|
1,042 |
973 |
$108K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,840 |
819 |
$107K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
1,633 |
1,402 |
$107K |
| 93041 |
|
13,600 |
12,283 |
$105K |
| 92610 |
|
1,183 |
1,143 |
$105K |
| 88142 |
|
3,471 |
3,406 |
$102K |
| 72040 |
|
2,584 |
2,448 |
$101K |
| 64484 |
|
2,370 |
1,919 |
$100K |
| 73502 |
|
5,041 |
4,616 |
$99K |
| 88185 |
|
1,174 |
729 |
$99K |
| 74420 |
|
1,128 |
1,062 |
$99K |
| 84703 |
|
26,226 |
24,093 |
$98K |
| 47562 |
|
66 |
65 |
$95K |
| J9070 |
Cyclophosphamide, 100 mg |
285 |
210 |
$95K |
| 64494 |
|
1,304 |
1,111 |
$95K |
| 36000 |
|
14,704 |
12,886 |
$94K |
| 92526 |
|
2,053 |
1,101 |
$93K |
| 90715 |
|
7,574 |
7,290 |
$92K |
| 73590 |
|
4,253 |
3,826 |
$92K |
| 77295 |
|
144 |
133 |
$91K |
| 72197 |
|
229 |
225 |
$91K |
| 72070 |
|
2,419 |
2,341 |
$91K |
| 86360 |
|
3,085 |
2,881 |
$91K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
38,897 |
28,404 |
$90K |
| 76870 |
|
2,051 |
1,969 |
$89K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
2,871 |
2,589 |
$88K |
| J9190 |
Injection, fluorouracil, 500 mg |
5,041 |
2,115 |
$88K |
| 91020 |
|
79 |
75 |
$88K |
| OP252 |
|
19,338 |
12,541 |
$87K |
| 74246 |
|
995 |
953 |
$87K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
117 |
70 |
$86K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
22,764 |
21,469 |
$86K |
| J1453 |
Injection, fosaprepitant, 1 mg |
402 |
283 |
$83K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
18,690 |
15,404 |
$82K |
| 81001 |
|
50,461 |
45,621 |
$82K |
| 88360 |
|
1,853 |
1,595 |
$81K |
| 73562 |
|
2,036 |
1,730 |
$80K |
| 96367 |
|
4,067 |
2,863 |
$79K |
| 10060 |
|
1,054 |
939 |
$79K |
| 86901 |
|
26,659 |
21,690 |
$78K |
| 80076 |
|
40,966 |
33,801 |
$78K |
| A0436 |
Rotary wing air mileage, per statute mile |
432 |
389 |
$78K |
| 92611 |
|
237 |
226 |
$77K |
| 85610 |
|
34,898 |
29,160 |
$77K |
| 73090 |
|
3,020 |
2,637 |
$77K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
42,245 |
37,510 |
$76K |
| J9045 |
Injection, carboplatin, 50 mg |
2,750 |
1,784 |
$75K |
| 78264 |
|
599 |
581 |
$74K |
| 76775 |
|
1,212 |
1,185 |
$74K |
| 83735 |
|
42,664 |
30,258 |
$74K |
| 58558 |
|
77 |
64 |
$72K |
| 73120 |
|
2,073 |
1,636 |
$72K |
| 20552 |
|
68 |
67 |
$70K |
| 86803 |
|
5,215 |
4,933 |
$70K |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
60 |
49 |
$69K |
| 85007 |
|
27,705 |
20,524 |
$69K |
| J3490 |
Unclassified drugs |
44,697 |
27,228 |
$69K |
| 86359 |
|
3,091 |
2,885 |
$68K |
| 74174 |
|
948 |
868 |
$68K |
| 96368 |
|
3,616 |
2,341 |
$67K |
| 77338 |
|
433 |
376 |
$66K |
| 76818 |
|
797 |
500 |
$65K |
| 74022 |
|
2,959 |
2,813 |
$64K |
| 86480 |
|
1,848 |
1,733 |
$63K |
| 84484 |
|
23,577 |
17,395 |
$63K |
| 76937 |
|
3,132 |
2,719 |
$62K |
| 45381 |
|
212 |
180 |
$61K |
| 87390 |
|
7,490 |
7,113 |
$61K |
| C1781 |
Mesh (implantable) |
278 |
256 |
$61K |
| 77080 |
|
1,817 |
1,693 |
$59K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
5,824 |
3,067 |
$59K |
| Q5117 |
Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg |
54 |
24 |
$59K |
| 93308 |
|
2,529 |
2,279 |
$58K |
| J1815 |
Injection, insulin, per 5 units |
5,225 |
2,278 |
$58K |
| 72146 |
|
241 |
229 |
$58K |
| 87088 |
|
21,716 |
19,797 |
$54K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
2,798 |
2,596 |
$53K |
| J9267 |
Injection, paclitaxel, 1 mg |
2,188 |
1,115 |
$53K |
| J9201 |
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg |
1,414 |
614 |
$53K |
| 74018 |
|
2,114 |
1,938 |
$52K |
| 76882 |
|
2,021 |
1,944 |
$51K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
43,965 |
34,253 |
$50K |
| 82728 |
|
7,214 |
6,631 |
$49K |
| 58100 |
|
65 |
63 |
$49K |
| 70544 |
|
233 |
226 |
$49K |
| 58301 |
|
40 |
39 |
$48K |
| 74241 |
|
454 |
453 |
$48K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
567 |
554 |
$48K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
2,131 |
1,852 |
$48K |
| 27447 |
|
65 |
54 |
$47K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
5,518 |
3,412 |
$47K |
| 73552 |
|
2,679 |
2,456 |
$47K |
| 88172 |
|
1,304 |
1,205 |
$46K |
| A0998 |
Ambulance response and treatment, no transport |
519 |
485 |
$46K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
13,847 |
12,396 |
$46K |
| J9171 |
Injection, docetaxel, 1 mg |
520 |
347 |
$45K |
| 0011A |
|
1,419 |
1,416 |
$44K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
6,420 |
4,210 |
$44K |
| 58661 |
|
48 |
41 |
$44K |
| J0491 |
Injection, anifrolumab-fnia, 1 mg |
15 |
13 |
$43K |
| OP270 |
|
3,035 |
2,645 |
$43K |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
4,109 |
1,954 |
$42K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
14,970 |
9,796 |
$41K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
10,186 |
8,362 |
$41K |
| 73523 |
|
854 |
797 |
$41K |
| J9395 |
Injection, fulvestrant, 25 mg |
110 |
89 |
$40K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
869 |
867 |
$39K |
| 73060 |
|
1,637 |
1,492 |
$39K |
| 88304 |
|
4,773 |
4,532 |
$39K |
| 64636 |
|
456 |
358 |
$39K |
| 86702 |
|
5,560 |
5,326 |
$38K |
| OP258 |
|
28,057 |
20,949 |
$38K |
| 74230 |
|
868 |
818 |
$38K |
| 76942 |
|
653 |
629 |
$38K |
| 83880 |
|
6,667 |
5,893 |
$37K |
| 0001A |
|
1,128 |
1,125 |
$37K |
| 74019 |
|
1,223 |
1,166 |
$37K |
| 87081 |
|
5,292 |
5,040 |
$37K |
| 73600 |
|
1,235 |
1,105 |
$37K |
| 84100 |
|
21,910 |
15,435 |
$37K |
| J9041 |
Injection, bortezomib, 0.1 mg |
46 |
12 |
$36K |
| 72080 |
|
1,150 |
1,124 |
$36K |
| 86701 |
|
5,532 |
5,322 |
$36K |
| 95886 |
|
440 |
431 |
$36K |
| 72157 |
|
115 |
112 |
$36K |
| 97165 |
|
2,920 |
2,505 |
$36K |
| 85730 |
|
15,330 |
13,674 |
$36K |
| 75574 |
|
158 |
157 |
$35K |
| 97166 |
|
712 |
697 |
$35K |
| J1644 |
Injection, heparin sodium, per 1000 units |
7,029 |
3,231 |
$34K |
| 78816 |
|
40 |
37 |
$33K |
| 88313 |
|
1,347 |
1,176 |
$33K |
| 86923 |
|
2,726 |
1,958 |
$33K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
2,771 |
2,309 |
$33K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
283 |
237 |
$32K |
| 76377 |
|
1,234 |
1,052 |
$32K |
| 81003 |
|
16,734 |
15,587 |
$32K |
| C1730 |
Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes) |
620 |
534 |
$32K |
| 76981 |
|
519 |
462 |
$32K |
| 83021 |
|
1,908 |
1,593 |
$31K |
| 77470 |
|
90 |
85 |
$31K |
| 82607 |
|
5,391 |
5,010 |
$30K |
| 0012A |
|
900 |
896 |
$30K |
| 95800 |
|
141 |
140 |
$30K |
| 0002A |
|
826 |
823 |
$30K |
| OP251 |
|
4,424 |
3,059 |
$30K |
| 72052 |
|
642 |
626 |
$30K |
| 83605 |
|
10,832 |
8,931 |
$30K |
| 83970 |
|
1,800 |
1,688 |
$29K |
| J9206 |
Injection, irinotecan, 20 mg |
934 |
491 |
$29K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
4,902 |
3,657 |
$28K |
| 87340 |
|
3,511 |
3,333 |
$28K |
| 64633 |
|
29 |
25 |
$28K |
| 51701 |
|
322 |
291 |
$28K |
| 83690 |
|
21,760 |
19,178 |
$27K |
| 72131 |
|
411 |
370 |
$27K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
18,344 |
8,837 |
$27K |
| 72114 |
|
684 |
670 |
$27K |
| 97164 |
|
1,357 |
1,328 |
$27K |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
7,445 |
5,700 |
$27K |
| C1892 |
Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away |
619 |
605 |
$27K |
| 90686 |
|
3,465 |
3,347 |
$27K |
| 12011 |
|
499 |
460 |
$26K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,718 |
1,572 |
$25K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
552 |
523 |
$24K |
| 87077 |
|
6,099 |
5,591 |
$24K |
| 95819 |
|
55 |
52 |
$24K |
| 83550 |
|
6,394 |
5,962 |
$23K |
| 84702 |
|
5,729 |
4,795 |
$23K |
| 42830 |
|
14 |
14 |
$23K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
9,258 |
8,145 |
$23K |
| 73522 |
|
657 |
654 |
$23K |
| 87641 |
|
2,757 |
2,162 |
$23K |
| 87070 |
|
3,908 |
3,575 |
$23K |
| 45330 |
|
26 |
25 |
$22K |
| 88173 |
|
2,231 |
2,010 |
$22K |
| 72120 |
|
675 |
646 |
$22K |
| 73200 |
|
184 |
165 |
$22K |
| 0031A |
|
797 |
794 |
$22K |
| C1788 |
Port, indwelling (implantable) |
461 |
407 |
$22K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
948 |
757 |
$22K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
270 |
254 |
$21K |
| 96377 |
|
1,320 |
940 |
$21K |
| 87186 |
|
5,776 |
5,317 |
$21K |
| 87640 |
|
2,631 |
2,083 |
$21K |
| 0064A |
|
702 |
686 |
$21K |
| 90733 |
|
337 |
315 |
$21K |
| 62322 |
|
30 |
29 |
$21K |
| J7050 |
Infusion, normal saline solution, 250 cc |
6,646 |
4,550 |
$21K |
| 84439 |
|
4,745 |
4,433 |
$20K |
| 72170 |
|
1,515 |
1,404 |
$20K |
| 77001 |
|
705 |
633 |
$20K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
98 |
98 |
$20K |
| 0004A |
|
691 |
686 |
$20K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
989 |
928 |
$20K |
| 99152 |
|
2,970 |
2,649 |
$19K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
26,344 |
21,213 |
$19K |
| 84153 |
|
2,361 |
2,237 |
$19K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
14,896 |
11,162 |
$19K |
| 77059 |
|
39 |
39 |
$19K |
| 99153 |
Mod sedat endo service >5yrs |
2,654 |
2,367 |
$19K |
| 87522 |
Neg quan hep c or qual rna |
1,521 |
1,396 |
$19K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,102 |
1,909 |
$18K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
16,065 |
9,779 |
$18K |
| 80329 |
|
3,612 |
2,569 |
$18K |
| 80074 |
|
1,534 |
1,397 |
$18K |
| 88184 |
|
876 |
739 |
$17K |
| 76098 |
|
317 |
296 |
$17K |
| 36590 |
|
13 |
12 |
$17K |
| 77061 |
|
1,577 |
1,319 |
$17K |
| 73100 |
|
482 |
409 |
$17K |
| 82784 |
|
1,785 |
1,592 |
$17K |
| A0433 |
Advanced life support, level 2 (als 2) |
69 |
66 |
$17K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
38 |
24 |
$17K |
| 86703 |
|
2,394 |
2,141 |
$16K |
| 86706 |
|
2,322 |
2,189 |
$16K |
| 45331 |
|
12 |
12 |
$16K |
| 70360 |
|
725 |
693 |
$16K |
| 64450 |
|
26 |
24 |
$16K |
| 73000 |
|
447 |
370 |
$15K |
| 93017 |
|
66 |
65 |
$15K |
| 81401 |
|
143 |
142 |
$15K |
| 87040 |
|
4,525 |
3,618 |
$15K |
| 64491 |
|
479 |
379 |
$15K |
| 58571 |
|
45 |
26 |
$15K |
| 96409 |
|
54 |
39 |
$15K |
| 83540 |
|
5,859 |
5,412 |
$15K |
| 82746 |
|
2,414 |
2,255 |
$14K |
| 26055 |
|
13 |
12 |
$14K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
2,089 |
1,712 |
$14K |
| 97802 |
|
1,518 |
1,265 |
$14K |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
1,191 |
1,078 |
$14K |
| 82570 |
|
9,587 |
8,972 |
$14K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
177 |
173 |
$14K |
| 86140 |
|
9,085 |
8,147 |
$13K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,386 |
950 |
$13K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
8,973 |
7,789 |
$13K |
| G0379 |
Direct admission of patient for hospital observation care |
155 |
127 |
$13K |
| 29515 |
|
475 |
451 |
$13K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
120 |
120 |
$13K |
| 83520 |
|
876 |
749 |
$13K |
| 82043 |
|
6,638 |
6,385 |
$12K |
| C1726 |
Catheter, balloon dilatation, non-vascular |
604 |
511 |
$12K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
2,748 |
1,875 |
$12K |
| 29125 |
|
325 |
297 |
$12K |
| 43251 |
|
18 |
14 |
$12K |
| 74220 |
|
92 |
92 |
$12K |
| 82330 |
|
2,485 |
2,055 |
$12K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
7,856 |
6,589 |
$12K |
| 97162 |
|
399 |
369 |
$12K |
| 86592 |
|
8,583 |
8,139 |
$12K |
| 92609 |
|
199 |
97 |
$12K |
| 12002 |
|
267 |
242 |
$11K |
| 73070 |
|
696 |
571 |
$11K |
| 72082 |
|
238 |
238 |
$11K |
| 38222 |
|
14 |
12 |
$11K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
9,442 |
8,454 |
$11K |
| 88112 |
|
1,335 |
1,243 |
$11K |
| 86762 |
|
1,556 |
1,488 |
$11K |
| 12001 |
|
480 |
422 |
$11K |
| 77417 |
|
676 |
432 |
$10K |
| 94618 |
|
396 |
385 |
$10K |
| 70487 |
|
217 |
203 |
$10K |
| 86704 |
|
1,411 |
1,308 |
$10K |
| 80320 |
|
5,664 |
5,212 |
$10K |
| 74221 |
|
207 |
191 |
$10K |
| 19301 |
|
18 |
12 |
$10K |
| 73620 |
|
468 |
391 |
$10K |
| J3489 |
Injection, zoledronic acid, 1 mg |
228 |
201 |
$10K |
| 81000 |
|
5,644 |
4,358 |
$10K |
| 70480 |
|
79 |
78 |
$10K |
| 86235 |
|
338 |
130 |
$10K |
| 83655 |
|
958 |
942 |
$10K |
| 85018 |
|
2,498 |
2,057 |
$10K |
| 87210 |
|
4,908 |
4,362 |
$10K |
| 87147 |
|
3,623 |
2,797 |
$9K |
| 83883 |
|
326 |
267 |
$9K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
145 |
142 |
$9K |
| 77002 |
|
208 |
186 |
$9K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
2,441 |
1,948 |
$9K |
| 86922 |
|
273 |
201 |
$9K |
| OP720 |
|
131 |
101 |
$9K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
37 |
37 |
$9K |
| 84403 |
|
484 |
448 |
$9K |
| 86038 |
|
1,653 |
1,517 |
$9K |
| 82550 |
|
4,972 |
4,218 |
$9K |
| 87205 |
|
3,371 |
3,092 |
$9K |
| 88302 |
|
629 |
583 |
$9K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
4,827 |
4,076 |
$9K |
| 82803 |
|
1,647 |
1,396 |
$9K |
| 85097 |
|
69 |
61 |
$9K |
| 90677 |
|
63 |
57 |
$8K |
| 87075 |
|
2,755 |
2,525 |
$8K |
| 85652 |
|
8,346 |
7,502 |
$8K |
| 0124A |
|
345 |
324 |
$8K |
| 84132 |
|
1,941 |
1,624 |
$8K |
| 88300 |
|
1,199 |
1,083 |
$8K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
6,000 |
3,887 |
$8K |
| J2997 |
Injection, alteplase recombinant, 1 mg |
27 |
26 |
$8K |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
503 |
493 |
$8K |
| 93923 |
|
29 |
28 |
$8K |
| 86160 |
|
1,397 |
923 |
$8K |
| J9000 |
Injection, doxorubicin hydrochloride, 10 mg |
298 |
185 |
$8K |
| 76801 |
|
315 |
305 |
$8K |
| 97535 |
Self-care/home management training, each 15 minutes |
1,172 |
776 |
$7K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
462 |
453 |
$7K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
43 |
42 |
$7K |
| 77072 |
|
159 |
158 |
$7K |
| 73718 |
|
27 |
26 |
$7K |
| J2060 |
Injection, lorazepam, 2 mg |
2,606 |
2,043 |
$7K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
6,884 |
4,631 |
$7K |
| 75561 |
|
14 |
14 |
$7K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,766 |
2,102 |
$7K |
| Q0114 |
Fern test |
1,515 |
1,314 |
$7K |
| 84295 |
|
1,618 |
1,348 |
$7K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
573 |
563 |
$7K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
457 |
449 |
$7K |
| 93975 |
|
26 |
24 |
$7K |
| 0134A |
|
300 |
278 |
$7K |
| 93312 |
|
12 |
12 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,646 |
3,515 |
$7K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
86 |
77 |
$7K |
| 0072A |
|
188 |
187 |
$7K |
| 90832 |
Psychotherapy, 30 minutes with patient |
166 |
99 |
$6K |
| 80179 |
|
1,881 |
1,672 |
$6K |
| 19081 |
|
14 |
14 |
$6K |
| 88311 |
|
1,109 |
1,015 |
$6K |
| 0054A |
|
225 |
220 |
$6K |
| 80069 |
|
2,358 |
2,015 |
$6K |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
5,906 |
4,588 |
$6K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
641 |
544 |
$6K |
| 97116 |
|
2,258 |
1,516 |
$6K |
| 82248 |
|
1,581 |
1,490 |
$6K |
| 85045 |
|
2,528 |
2,074 |
$6K |
| 82247 |
|
1,452 |
1,187 |
$6K |
| 0071A |
|
147 |
147 |
$6K |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
655 |
411 |
$5K |
| G0390 |
Trauma response team associated with hospital critical care service |
43 |
39 |
$5K |
| 86870 |
|
216 |
180 |
$5K |
| G0008 |
Administration of influenza virus vaccine |
459 |
439 |
$5K |
| 83615 |
|
2,535 |
1,970 |
$5K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
13 |
13 |
$5K |
| 86905 |
|
737 |
399 |
$5K |
| 38900 |
|
56 |
39 |
$5K |
| J8501 |
Aprepitant, oral, 5 mg |
528 |
480 |
$5K |
| 0051A |
|
144 |
139 |
$5K |
| 59200 |
|
13 |
12 |
$5K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
925 |
600 |
$5K |
| 86255 |
|
1,087 |
969 |
$5K |
| 81329 |
|
48 |
48 |
$5K |
| 84311 |
|
770 |
761 |
$5K |
| 70543 |
|
15 |
15 |
$4K |
| 82105 |
|
482 |
435 |
$4K |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
1,257 |
1,160 |
$4K |
| 84146 |
|
309 |
295 |
$4K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
227 |
219 |
$4K |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
1,295 |
739 |
$4K |
| 29888 |
|
15 |
13 |
$4K |
| 84156 |
|
2,097 |
1,782 |
$4K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
724 |
669 |
$4K |
| C1758 |
Catheter, ureteral |
1,289 |
1,126 |
$4K |
| 85379 |
|
3,834 |
3,564 |
$4K |
| 77333 |
|
58 |
58 |
$4K |
| 77387 |
|
242 |
24 |
$4K |
| 83516 |
|
630 |
561 |
$4K |
| 76000 |
|
106 |
105 |
$4K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
358 |
346 |
$4K |
| 77014 |
|
69 |
12 |
$4K |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,638 |
1,160 |
$3K |
| C2625 |
Stent, non-coronary, temporary, with delivery system |
49 |
40 |
$3K |
| 77012 |
|
40 |
38 |
$3K |
| 87324 |
|
111 |
104 |
$3K |
| 90834 |
Psychotherapy, 45 minutes with patient |
111 |
58 |
$3K |
| 82272 |
|
620 |
601 |
$3K |
| 97010 |
|
494 |
185 |
$3K |
| 88312 |
|
367 |
341 |
$3K |
| 82805 |
|
1,096 |
951 |
$3K |
| S2900 |
Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) |
123 |
81 |
$3K |
| J7297 |
Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg |
37 |
34 |
$3K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
31 |
29 |
$3K |
| 82533 |
|
467 |
374 |
$3K |
| 92553 |
|
42 |
40 |
$3K |
| 93325 |
|
12 |
12 |
$3K |
| 80164 |
|
458 |
393 |
$3K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1,777 |
1,360 |
$3K |
| 86769 |
|
367 |
337 |
$3K |
| 87529 |
|
360 |
243 |
$3K |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
2,432 |
2,069 |
$3K |
| 0052A |
|
87 |
82 |
$3K |
| 84550 |
|
1,877 |
1,515 |
$3K |
| 86708 |
|
281 |
276 |
$3K |
| 64447 |
|
22 |
17 |
$3K |
| 83986 |
|
827 |
816 |
$3K |
| 88331 |
|
134 |
127 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
6,869 |
5,893 |
$2K |
| 94660 |
|
107 |
85 |
$2K |
| 84481 |
|
444 |
413 |
$2K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
16 |
16 |
$2K |
| 90732 |
|
208 |
208 |
$2K |
| 87206 |
|
459 |
396 |
$2K |
| 82977 |
|
833 |
755 |
$2K |
| 83010 |
|
271 |
238 |
$2K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
32 |
29 |
$2K |
| 87102 |
|
408 |
383 |
$2K |
| 91320 |
|
32 |
32 |
$2K |
| 90658 |
|
182 |
179 |
$2K |
| 84165 |
|
535 |
461 |
$2K |
| 72192 |
|
12 |
12 |
$2K |
| 99205 |
Prolong outpt/office vis |
14 |
14 |
$2K |
| 82310 |
|
1,750 |
1,619 |
$2K |
| 93880 |
|
12 |
12 |
$2K |
| 82010 |
|
1,411 |
1,224 |
$2K |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
282 |
262 |
$2K |
| 82565 |
|
876 |
826 |
$2K |
| 85384 |
|
236 |
194 |
$2K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
100 |
95 |
$2K |
| 84402 |
|
101 |
91 |
$2K |
| J1630 |
Injection, haloperidol, up to 5 mg |
2,964 |
2,434 |
$2K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,728 |
1,813 |
$2K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
20 |
16 |
$2K |
| 82951 |
|
370 |
347 |
$2K |
| 86618 |
|
186 |
165 |
$2K |
| 0399T |
|
13 |
13 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
341 |
328 |
$2K |
| 92552 |
|
12 |
12 |
$2K |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
122 |
119 |
$2K |
| J1940 |
Injection, furosemide, up to 20 mg |
1,273 |
826 |
$2K |
| 84425 |
|
145 |
133 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
57 |
56 |
$2K |
| J9060 |
Injection, cisplatin, powder or solution, 10 mg |
109 |
52 |
$1K |
| 92524 |
|
25 |
25 |
$1K |
| 86334 |
|
231 |
209 |
$1K |
| 76376 |
|
23 |
23 |
$1K |
| 87807 |
|
138 |
137 |
$1K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
4,012 |
2,805 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
752 |
673 |
$1K |
| OP271 |
|
3,103 |
2,969 |
$1K |
| 82378 |
|
173 |
145 |
$1K |
| J2790 |
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
27 |
26 |
$1K |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
2,624 |
2,216 |
$1K |
| 36416 |
|
278 |
229 |
$1K |
| 82270 |
|
173 |
162 |
$1K |
| 38792 |
|
20 |
14 |
$1K |
| 0034A |
|
57 |
55 |
$1K |
| C9113 |
Injection, pantoprazole sodium, per vial |
2,556 |
1,243 |
$1K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
513 |
323 |
$1K |
| 87045 |
|
200 |
185 |
$1K |
| 64495 |
|
26 |
26 |
$997.43 |
| 99195 |
|
16 |
12 |
$993.85 |
| 84145 |
|
380 |
365 |
$978.77 |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
91 |
89 |
$970.66 |
| 86430 |
|
841 |
762 |
$918.71 |
| 72190 |
|
25 |
24 |
$894.53 |
| 89051 |
|
452 |
393 |
$888.57 |
| 76604 |
|
29 |
26 |
$863.13 |
| 82040 |
|
1,050 |
910 |
$856.19 |
| 90739 |
|
26 |
26 |
$843.33 |
| 90670 |
|
38 |
38 |
$841.22 |
| 70355 |
|
110 |
106 |
$823.15 |
| 99385 |
|
12 |
12 |
$806.82 |
| 83001 |
|
79 |
72 |
$799.40 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
5,672 |
4,788 |
$783.37 |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
19 |
12 |
$759.04 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
370 |
181 |
$758.50 |
| 83521 |
|
196 |
122 |
$751.91 |
| 90480 |
|
32 |
32 |
$720.00 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
1,040 |
847 |
$702.89 |
| 76885 |
|
12 |
12 |
$694.53 |
| 86304 |
|
102 |
88 |
$693.17 |
| 87118 |
|
78 |
72 |
$657.54 |
| 0003A |
|
23 |
23 |
$657.08 |
| J1953 |
Injection, levetiracetam, 10 mg |
219 |
171 |
$619.20 |
| 82945 |
|
104 |
94 |
$595.57 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
530 |
461 |
$574.85 |
| C1782 |
Morcellator |
41 |
25 |
$541.65 |
| 93888 |
|
12 |
12 |
$490.02 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,614 |
1,276 |
$476.98 |
| 87899 |
|
111 |
90 |
$460.18 |
| 71101 |
|
12 |
12 |
$451.36 |
| 83921 |
|
44 |
38 |
$440.42 |
| 12013 |
|
16 |
14 |
$422.82 |
| 73140 |
|
26 |
25 |
$409.19 |
| 83993 |
|
27 |
26 |
$408.98 |
| J2785 |
Injection, regadenoson, 0.1 mg |
13 |
13 |
$408.78 |
| 71100 |
|
27 |
27 |
$393.60 |
| 36593 |
|
12 |
12 |
$378.52 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
58 |
54 |
$373.58 |
| 82140 |
|
172 |
147 |
$373.18 |
| 88333 |
|
62 |
51 |
$372.43 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
1,393 |
989 |
$359.65 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
497 |
432 |
$352.21 |
| 87209 |
|
53 |
48 |
$327.65 |
| S0190 |
Mifepristone, oral, 200 mg |
31 |
27 |
$320.60 |
| 82150 |
|
136 |
118 |
$313.50 |
| 90791 |
Psychiatric diagnostic evaluation |
26 |
24 |
$303.16 |
| 87517 |
|
12 |
12 |
$273.29 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
13 |
13 |
$272.85 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
1,580 |
643 |
$263.26 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
198 |
173 |
$262.95 |
| J9370 |
Vincristine sulfate, 1 mg |
35 |
24 |
$262.29 |
| 83002 |
|
30 |
28 |
$256.51 |
| J0703 |
Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg |
112 |
64 |
$248.18 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
446 |
385 |
$244.55 |
| 87563 |
|
102 |
99 |
$224.45 |
| 84157 |
|
158 |
140 |
$222.39 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
450 |
344 |
$219.11 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
30 |
30 |
$214.64 |
| 87338 |
|
25 |
25 |
$212.85 |
| 90632 |
|
12 |
12 |
$208.09 |
| 86885 |
|
19 |
12 |
$187.67 |
| 86705 |
|
15 |
14 |
$178.40 |
| 87046 |
|
188 |
173 |
$172.54 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
29 |
26 |
$160.46 |
| 87116 |
|
108 |
87 |
$149.86 |
| 80202 |
|
23 |
12 |
$144.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
298 |
227 |
$142.29 |
| J1817 |
Insulin for administration through dme (i.e., insulin pump) per 50 units |
900 |
472 |
$136.51 |
| 85014 |
|
231 |
167 |
$133.36 |
| 82172 |
|
13 |
12 |
$129.42 |
| 86787 |
|
12 |
12 |
$123.48 |
| 87177 |
|
53 |
48 |
$111.75 |
| 29505 |
|
26 |
25 |
$104.40 |
| J2150 |
Injection, mannitol, 25% in 50 ml |
58 |
28 |
$99.76 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
254 |
141 |
$98.95 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
355 |
227 |
$98.56 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
183 |
98 |
$90.02 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
686 |
538 |
$86.43 |
| 86376 |
|
13 |
13 |
$83.44 |
| 84460 |
|
57 |
55 |
$80.86 |
| 83519 |
|
13 |
12 |
$80.72 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
121 |
91 |
$78.18 |
| 85041 |
|
123 |
83 |
$74.14 |
| J3250 |
Injection, trimethobenzamide hcl, up to 200 mg |
20 |
12 |
$72.08 |
| 82274 |
|
28 |
28 |
$71.00 |
| 80177 |
|
31 |
27 |
$65.72 |
| J0741 |
Injection, cabotegravir and rilpivirine, 2mg/3mg |
182 |
150 |
$64.85 |
| 86880 |
|
25 |
13 |
$61.50 |
| 84300 |
|
29 |
24 |
$58.43 |
| 89060 |
|
14 |
12 |
$55.66 |
| 90656 |
|
19 |
18 |
$55.39 |
| 82657 |
|
23 |
14 |
$51.60 |
| 86593 |
|
17 |
14 |
$51.38 |
| J7510 |
Prednisolone oral, per 5 mg |
495 |
445 |
$48.95 |
| 90756 |
|
16 |
16 |
$48.60 |
| 92522 |
|
12 |
12 |
$48.17 |
| J1836 |
Injection, metronidazole, 10 mg |
206 |
140 |
$43.03 |
| J1956 |
Injection, levofloxacin, 250 mg |
44 |
38 |
$37.62 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
106 |
102 |
$37.19 |
| J3411 |
Injection, thiamine hcl, 100 mg |
120 |
71 |
$31.05 |
| 82435 |
|
341 |
256 |
$27.36 |
| 82947 |
|
200 |
161 |
$27.10 |
| 81002 |
|
35 |
35 |
$26.75 |
| A4649 |
Surgical supply; miscellaneous |
22 |
17 |
$25.81 |
| J1643 |
Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units |
461 |
146 |
$18.47 |
| Q0164 |
Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
32 |
24 |
$16.00 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
232 |
167 |
$15.14 |
| 89050 |
|
37 |
28 |
$9.62 |
| 82962 |
|
18 |
16 |
$7.80 |
| 86308 |
|
12 |
12 |
$7.60 |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
12 |
12 |
$7.47 |
| 91312 |
|
367 |
340 |
$4.00 |
| 91305 |
|
582 |
532 |
$2.00 |
| 91303 |
|
817 |
811 |
$1.00 |
| 91307 |
|
328 |
314 |
$0.01 |
| J0737 |
Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg |
14 |
12 |
$0.00 |
| 90611 |
|
96 |
63 |
$0.00 |
| D9230 |
Inhalation of nitrous oxide / analgesia, anxiolysis |
16 |
15 |
$0.00 |
| 64634 |
|
15 |
13 |
$0.00 |
| 91313 |
|
299 |
278 |
$0.00 |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
35 |
24 |
$0.00 |
| 94664 |
|
64 |
60 |
$0.00 |
| 91300 |
|
2,644 |
2,457 |
$0.00 |
| Q0245 |
Injection, bamlanivimab and etesevimab, 2100 mg |
20 |
20 |
$0.00 |
| J0184 |
Injection, amisulpride, 1 mg |
12 |
12 |
$0.00 |
| 38525 |
|
21 |
15 |
$0.00 |
| 91306 |
|
687 |
666 |
$0.00 |
| 91301 |
|
2,337 |
2,303 |
$0.00 |
| Q0222 |
Injection, bebtelovimab, 175 mg |
44 |
41 |
$0.00 |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
21 |
13 |
$0.00 |
| Q9992 |
Injection, buprenorphine extended-release (sublocade), greater than 100 mg |
15 |
15 |
$0.00 |
| OP637 |
|
345 |
187 |
$0.00 |
| Q9968 |
Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg |
16 |
13 |
$0.00 |
| Q0247 |
Injection, sotrovimab, 500 mg |
29 |
27 |
$0.00 |